Abstract PD09-05: Single nucleotide polymorphism of XRCC1 which participates in DNA repair mechanism predicts clinical outcome in relapsed or metastatic breast cancer patients treated with S1 and oxaliplatin chemotherapy: Results from multicenter prospective study (TORCH_KCSG BR07-03)

Dna Repair ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Nucleotide Polymorphism ◽

Repair Mechanism ◽

Single Nucleotide ◽

Multicenter Prospective Study

Combined analysis of copy number alterations by single-nucleotide polymorphism array and MYC status in non-metastatic breast cancer patients: comparison according to the circulating tumor cell status

Tumor Biology ◽

10.1007/s13277-014-2668-4 ◽

2014 ◽

Vol 36 (2) ◽

pp. 711-718

Author(s):

R. Nadal ◽

M. Salido ◽

L. Nonell ◽

M. Rodríguez-Rivera ◽

E. Puigdecanet ◽

...

Keyword(s):

Breast Cancer ◽

Copy Number ◽

Single Nucleotide Polymorphism Array ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Copy Number Alterations ◽

Breast Cancer Patients ◽

Nucleotide Polymorphism ◽

162 ORAL A single nucleotide polymorphism in the CCND1 gene is associated with decreased risk of developing metastases in female breast cancer patients

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80460-4 ◽

2005 ◽

Vol 3 (2) ◽

pp. 46-47

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Female Breast Cancer ◽

Breast Cancer Patients ◽

Nucleotide Polymorphism ◽

Single Nucleotide ◽

Ccnd1 Gene ◽

Female Breast

Single Nucleotide Polymorphism (SNP) in RASSF1 and Clinical Outcomes of Breast Cancer Patients Treated with Neoadjuvant Docetaxel/Doxorubicin Chemotherapy.

10.1158/0008-5472.sabcs-09-6061 ◽

2009 ◽

Author(s):

B. Keam ◽

H. Kim ◽

S. Im ◽

S. Han ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Clinical Outcomes ◽

Breast Cancer Patients ◽

Nucleotide Polymorphism ◽

Abstract 5298: Two distinctive single nucleotide polymorphisms determine liver metastases responses to docetaxel plus thiotepa for metastatic breast cancer patients.

10.1158/1538-7445.am2013-5298 ◽

2013 ◽

Author(s):

Jing Yu ◽

Ningning Dong ◽

Ying Yan ◽

Bin Shao ◽

Lijun Di ◽

...

Keyword(s):

Breast Cancer ◽

Single Nucleotide Polymorphisms ◽

Liver Metastases ◽

Cancer Patients ◽

Metastatic Breast ◽

Nucleotide Polymorphisms ◽

Breast Cancer Patients ◽

Letrozole efficacy is related to human aromatase CYP19 single nucleotide polymorphisms (SNPs) in metastatic breast cancer patients

10.1200/jco.2004.22.90140.507 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 507-507

Author(s):

B. Lloveras ◽

M. Monzo ◽

R. Colomer ◽

A. Llombart ◽

M. Ramos ◽

...

Keyword(s):

Breast Cancer ◽

Single Nucleotide Polymorphisms ◽

Cancer Patients ◽

Metastatic Breast ◽

Nucleotide Polymorphisms ◽

Breast Cancer Patients ◽

Single Nucleotide ◽

Human Aromatase

Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients

International Journal of Clinical Oncology ◽

10.1007/s10147-015-0913-5 ◽

2015 ◽

Vol 21 (3) ◽

pp. 539-547 ◽

Cited By ~ 5

Author(s):

Yukari Hato ◽

Naoto Kondo ◽

Nobuyasu Yoshimoto ◽

Yumi Endo ◽

Tomoko Asano ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Hormone Receptor ◽

Prognostic Impact ◽

Breast Cancer Patients ◽

Nucleotide Polymorphism ◽

Single Nucleotide ◽

Hormone Receptor Positive ◽

Positive Breast Cancer

63P Study of single nucleotide polymorphism of thymocyte selection associated high mobility group box 3 and fibroblast growth factor receptor 2 genes in breast cancer patients

Annals of Oncology ◽

10.1016/j.annonc.2020.03.197 ◽

2020 ◽

Vol 31 ◽

pp. S36

Author(s):

A.M. Alhanafy ◽

M. Hammoudah ◽

A. Dawood ◽

M. Abouelenin

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Fibroblast Growth Factor Receptor ◽

Growth Factor Receptor ◽

High Mobility ◽

Fibroblast Growth ◽

Breast Cancer Patients ◽

Nucleotide Polymorphism ◽

Letrozole efficacy is related to human aromatase CYP19 single nucleotide polymorphisms (SNPs) in metastatic breast cancer patients

10.1200/jco.2004.22.14_suppl.507 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 507-507 ◽

Cited By ~ 3

Author(s):

B. Lloveras ◽

M. Monzo ◽

R. Colomer ◽

A. Llombart ◽

M. Ramos ◽

...

Keyword(s):

Breast Cancer ◽

Single Nucleotide Polymorphisms ◽

Cancer Patients ◽

Metastatic Breast ◽

Nucleotide Polymorphisms ◽

Breast Cancer Patients ◽

Single Nucleotide ◽

Human Aromatase

Use of MDR1/ABCB1 single nucleotide polymorphism (SNP) as a prognostic factor for breast cancer patients receiving docetaxel + doxorubicin neoadjuvant chemotherapy

10.1200/jco.2008.26.15_suppl.569 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 569-569

Author(s):

H. J. Kim ◽

B. Keam ◽

S. Im ◽

H. S. Ham ◽

D. Oh ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factor ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Nucleotide Polymorphism ◽

MDR1/ABCB1 single nucleotide polymorphism (SNP) as a possible prognostic factor in breast cancer patients receiving docetaxel and doxorubicin neoadjuvant chemotherapy.

10.1200/jco.2010.28.15_suppl.585 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 585-585 ◽

Cited By ~ 1

Author(s):

H. Kim ◽

B. Keam ◽

S. Im ◽

H. Ham ◽

S. Han ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factor ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Nucleotide Polymorphism ◽